Nasdaq
CUVL
Clinuvel Pharmaceuticals Limited
- Miscellaneous
- Australia
- 1 day
- +3.4%
- 1 month
- −7.0%
- 1 year
- −15.1%
$6.72 · Mkt cap $337M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Clinuvel Pharmaceuticals Limited
$6.72 · Mkt cap $337M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Clinuvel Pharmaceuticals Limited trades under the ticker CUVL on Nasdaq, in the Miscellaneous sector. Its market capitalisation is $337M. The last closing price was $6.72, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −15.1%, and −7.0% over the past month. Returns are price returns and exclude dividends.
This page exists because CUVL is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.